Novartis India shareholders can tender shares in open offer
FY – FY 2026
Do Not Buy
Symbol
NOVARTIND
Company
Novartis India Ltd
Category
ACQUISITION
Source
Stock Exchange Filing
Total Equity Shares Offered
64,19,608
Equity Shares Tendered in Demat Form
0
Equity Shares Tendered in Physical Form
10
Percentage of Offer Size Tendered
0.00%
News Summary
Axis Capital Ltd shared updates on an open offer for Novartis India shares.
The offer is for up to 64.2 lakhs equity shares from public shareholders.
As of June 19, 2026, no shares have been tendered in the demat account and only 10 shares in physical form.
Why This Matters
This open offer could change the ownership structure of Novartis India.
Investors should watch how many shares others tender to see if the offer succeeds.
The outcome may affect the stock price and future plans of the company.
Fundamental Backdrop (FY – FY 2026)
Metric
Value
Number of Equity Shares Tendered in Demat Form
Number of Equity Shares Tendered in Physical Form
Analyst's View
This open offer shows interest from major investors in taking control of Novartis India.
The low number of tendered shares so far suggests limited public participation.
Investors may want to monitor if more shares get tendered as the offer progresses.
Do Not Buy
Avoid
Very few shares have been tendered so far, which suggests low interest from public shareholders.
Key Considerations
Check if the offer will be completed and accepted by all parties.
Watch for any changes in company leadership or strategy.
Consider how this affects long-term investment plans.
HorizonMedium term
Confidence LevelMedium
⚠️
Disclaimer
This analysis is for informational purposes only and does not constitute financial advice.
Do your own research and consult a qualified financial professional before making any investment decisions.